{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:41:48Z","timestamp":1758044508256,"version":"3.44.0"},"reference-count":199,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128180846"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-818084-6.00011-8","type":"book-chapter","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T06:47:17Z","timestamp":1592549237000},"page":"399-433","source":"Crossref","is-referenced-by-count":0,"title":["Gene editing and central nervous system regeneration"],"prefix":"10.1016","author":[{"given":"Sara Monteiro","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.57.3.418","article-title":"The global burden of disease study: implications for neurology","volume":"57","author":"Menken","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000495197","article-title":"Global burden of neurological disorders: from global burden of disease estimates to actions","volume":"52","author":"Feigin","year":"2019","journal-title":"Neuroepidemiology"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/85454","article-title":"In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice","volume":"7","author":"Consiglio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hum.2013.200","article-title":"Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington\u2019s disease","volume":"25","author":"Stanek","year":"2014","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib8","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymthe.2003.10.013","article-title":"Chance or necessity? Insertional mutagenesis in gene therapy and its consequences","volume":"9","author":"Baum","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib10","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/nar\/gki324","article-title":"A computational study of off-target effects of RNA interference","volume":"33","author":"Qiu","year":"2005","journal-title":"Nucleic Acid. Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib12","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-2836(70)90149-X","article-title":"A restriction enzyme from Hemophilus influenzae. I. Purification and general properties","volume":"51","author":"Smith","year":"1970","journal-title":"J. Mol. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib14","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1073\/pnas.68.12.2913","article-title":"Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzae","volume":"68","author":"Danna","year":"1971","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0022-2836(70)90150-6","article-title":"A restriction enzyme from Hemophilus influenzae. II","volume":"51","author":"Kelly","year":"1970","journal-title":"J. Mol. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","article-title":"Insertion of DNA sequences into the human chromosomal \u03b2-globin locus by homologous recombination","volume":"317","author":"Smithies","year":"1985","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.2660260","article-title":"Altering the genome by homologous recombination","volume":"244","author":"Capecchi","year":"1989","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0092-8674(86)90463-0","article-title":"High frequency targeting of genes to specific sites in the mammalian genome","volume":"44","author":"Thomas","year":"1986","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrg1619","article-title":"Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century","volume":"6","author":"Capecchi","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib20","first-page":"8096","article-title":"Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease","volume":"14","author":"Rouet","year":"1994","journal-title":"Mol. Cell Biol"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/genetics\/122.3.519","article-title":"Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae","volume":"122","author":"Rudin","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/MCB.21.1.289-297.2001","article-title":"Stimulation of homologous recombination through targeted cleavage by chimeric nucleases","volume":"21","author":"Bibikova","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib23","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1093\/nar\/gkl720","article-title":"A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences","volume":"34","author":"Smith","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nbt1319","article-title":"An improved zinc-finger nuclease architecture for highly specific genome editing","volume":"25","author":"Miller","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.1178817","article-title":"A simple cipher governs DNA recognition by TAL effectors","volume":"326","author":"Moscou","year":"2009","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib28","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1178811","article-title":"Breaking the code of DNA binding specificity of TAL-type III effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1534\/genetics.110.120717","article-title":"Targeting DNA double-strand breaks with TAL effector nucleases","volume":"186","author":"Christian","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib31","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"eLife"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.str.2010.12.003","article-title":"Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification","volume":"19","author":"Stoddard","year":"2011","journal-title":"Structure"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00018-009-0188-y","article-title":"Homing endonucleases: from basics to therapeutic applications","volume":"67","author":"Marcaida","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib35","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/nar\/gkl645","article-title":"Homing endonuclease I-CreI derivatives with novel DNA target specificities","volume":"34","author":"Rosen","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib36","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1093\/nar\/gkf495","article-title":"Mutations altering the cleavage specificity of a homing endonuclease","volume":"30","author":"Seligman","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jmb.2004.07.031","article-title":"Isolation and characterization of new homing endonuclease specificities at individual target site positions","volume":"342","author":"Sussman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/156652311794520111","article-title":"Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy","volume":"11","author":"Silva","year":"2011","journal-title":"Curr. Gene. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib39","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib40","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1073\/pnas.95.18.10570","article-title":"FokI dimerization is required for DNA cleavage","volume":"95","author":"Bitinaite","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib41","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.biophys.29.1.183","article-title":"DNA recognition by Cys2His2 zinc finger proteins","volume":"29","author":"Wolfe","year":"2000","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2008.06.016","article-title":"Rapid \u201copen-source\u201d engineering of customized zinc-finger nucleases for highly efficient gene modification","volume":"31","author":"Maeder","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2011.431","article-title":"A transcription activator-like effector toolbox for genome engineering","volume":"7","author":"Sanjana","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib45","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/nar\/gkr218","article-title":"Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting","volume":"39","author":"Cermak","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/aps.2017.2","article-title":"Therapeutic gene editing: delivery and regulatory perspectives","volume":"38","author":"Shim","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib48","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)80542-5","article-title":"A perfect message: RNA surveillance and nonsense-mediated decay","volume":"96","author":"Hentze","year":"1999","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tibtech.2015.02.011","article-title":"Genome editing at the crossroads of delivery, specificity, and fidelity","volume":"33","author":"Maggio","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib52","first-page":"873","article-title":"DNA double-strand break repair by homologous recombination","volume":"383","author":"van den Bosch","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2041-9414-3-9","article-title":"Pathway choice in DNA double strand break repair: observations of a balancing act","volume":"3","author":"Brandsma","year":"2012","journal-title":"Genome Integr."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib55","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","article-title":"Biological significance of a family of regularly spaced repeats in the genomes of Archaea, bacteria and mitochondria","volume":"36","author":"Mojica","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib57","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib59","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib60","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib61","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib62","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","article-title":"Small CRISPR RNAs guide antiviral defense in prokaryotes","volume":"321","author":"Brouns","year":"2008","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molcel.2011.10.023","article-title":"Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs","volume":"45","author":"Hale","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cell.2009.07.040","article-title":"RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex","volume":"139","author":"Hale","year":"2009","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib65","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1126\/science.1165771","article-title":"CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA","volume":"322","author":"Marraffini","year":"2008","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib66","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JB.01412-07","article-title":"Phage response to CRISPR-encoded resistance in Streptococcus thermophilus","volume":"190","author":"Deveau","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib67","first-page":"20180087","article-title":"Origins and evolution of CRISPR-Cas systems","volume":"374","author":"Koonin","year":"2019","journal-title":"Philos. Trans. R. Soc. London. Ser. B, Biol. Sci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib70","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1093\/nar\/gkr606","article-title":"The Streptococcus thermophilus CRISPR\/Cas system provides immunity in Escherichia coli","volume":"39","author":"Sapranauskas","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib71","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad.Sci. USA"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib72","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib73","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib75","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib76","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib78","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib79","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib80","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1093\/nar\/gkt076","article-title":"Mammalian base excision repair: the forgotten archangel","volume":"41","author":"Dianov","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib81","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib82","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.2908","article-title":"Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing","volume":"32","author":"Tsai","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib83","doi-asserted-by":"crossref","first-page":"e0133373","DOI":"10.1371\/journal.pone.0133373","article-title":"Efficient fdCas9 synthetic endonuclease with improved specificity for precise genome engineering","volume":"10","author":"Aouida","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt.2909","article-title":"Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification","volume":"32","author":"Guilinger","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib85","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1038\/srep11221","article-title":"Generation of mutant mice via the CRISPR\/Cas9 system using FokI-dCas9","volume":"5","author":"Hara","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib87","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib88","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4161\/rna.23764","article-title":"Protospacer recognition motifs: mixed identities and functional diversity","volume":"10","author":"Shah","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib89","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib90","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib91","doi-asserted-by":"crossref","first-page":"1247997","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","article-title":"CRISPR\/Cas9 editing of the mutant huntingtin allele in vitro and in vivo","volume":"25","author":"Monteys","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib93","first-page":"4566","article-title":"Permanent inactivation of Huntington\u2019s disease mutation by personalized allele-specific CRISPR\/Cas9","volume":"25","author":"Shin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib95","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib96","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib97","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nmeth.2681","article-title":"Orthogonal Cas9 proteins for RNA-guided gene regulation and editing","volume":"10","author":"Esvelt","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib98","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cell.2016.04.003","article-title":"Crystal structure of Cpf1 in complex with guide RNA and target DNA","volume":"165","author":"Yamano","year":"2016","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature17945","article-title":"The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA","volume":"532","author":"Fonfara","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/jvi.45.2.555-564.1983","article-title":"Nucleotide sequence and organization of the adeno-associated virus 2 genome","volume":"45","author":"Srivastava","year":"1983","journal-title":"J. Virology"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib102","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13059-015-0817-8","article-title":"Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications","volume":"16","author":"Friedland","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib103","doi-asserted-by":"crossref","first-page":"eaar3952","DOI":"10.1126\/sciadv.aar3952","article-title":"In vivo genome editing improves motor function and extends survival in a mouse model of ALS","volume":"3","author":"Gaj","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib104","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib105","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib106","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","article-title":"The self-inactivating KamiCas9 system for the editing of CNS disease","volume":"20","author":"Merienne","year":"2017","journal-title":"Genes. Cell Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib107","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2018.00075","article-title":"Precise excision of the CAG tract from the Huntingtin gene by Cas9 nickases","volume":"12","author":"Dabrowska","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/scd.2017.0209","article-title":"CRISPR\/Cas9-targeted deletion of polyglutamine in spinocerebellar ataxia type 3-derived iPSCs","volume":"27","author":"Ouyang","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib109","doi-asserted-by":"crossref","first-page":"e0165499","DOI":"10.1371\/journal.pone.0165499","article-title":"Reactivation of FMR1 by CRISPR\/Cas9-mediated deletion of the expanded CGG-repeat of the fragile X chromosome","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","article-title":"CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs","volume":"8","author":"Wang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib111","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","article-title":"Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells","volume":"8","author":"Xu","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib112","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14336\/AD.2013.0400295","article-title":"Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials","volume":"4","author":"Gordon","year":"2013","journal-title":"Aging Dis."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib113","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib114","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/35086072","article-title":"Alzheimer\u2019s disease and abeta toxicity: from top to bottom","volume":"2","author":"Small","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jalz.2015.06.1883","article-title":"Alzheimer\u2019s disease neuroimaging initiative: a decade of progress in Alzheimer\u2019s disease","volume":"11","author":"Thies","year":"2015","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib116","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","article-title":"BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics","volume":"10","author":"Roberds","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tips.2013.01.008","article-title":"Beta-secretase: its biology as a therapeutic target in diseases","volume":"34","author":"Wang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib118","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib119","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib120","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib121","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"eLife"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib122","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","article-title":"Glutamine repeats and neurodegeneration","volume":"23","author":"Zoghbi","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib123","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.genom.1.1.281","article-title":"Trinucleotide repeats: mechanisms and pathophysiology","volume":"1","author":"Cummings","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib124","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-971172","article-title":"Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3","volume":"27","author":"Paulson","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib127","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng0793-300","article-title":"The gene for Machado-Joseph disease maps to human chromosome 14q","volume":"4","author":"Takiyama","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib130","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease","volume":"135","author":"Sim\u00f5es","year":"2012","journal-title":"Brain."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib131","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1093\/hmg\/ddu209","article-title":"Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado\u2013Joseph disease","volume":"23","author":"Sim\u00f5es","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib132","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/hmg\/dds449","article-title":"Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)","volume":"22","author":"H\u00fcbener","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib133","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awt144","article-title":"Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease","volume":"136","author":"Nascimento-Ferreira","year":"2013","journal-title":"Brain."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib134","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib135","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1038\/srep28220","article-title":"Fibroblasts of Machado Joseph disease patients reveal autophagy impairment","volume":"6","author":"Onofre","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib136","doi-asserted-by":"crossref","first-page":"7782","DOI":"10.1523\/JNEUROSCI.1142-17.2017","article-title":"Calpain inhibition is protective in Machado-Joseph disease Zebrafish due to induction of autophagy","volume":"37","author":"Watchon","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib137","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cmet.2014.09.001","article-title":"Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy","volume":"20","author":"Dubinsky","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib138","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/WCO.0b013e3282f7673d","article-title":"New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease)","volume":"21","author":"R\u00fcb","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib139","first-page":"17","article-title":"Machado-Joseph disease","volume":"3","author":"Sudarsky","year":"1995","journal-title":"Clin. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features","volume":"39","author":"Durr","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib141","doi-asserted-by":"crossref","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib142","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib143","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib144","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/342931","article-title":"Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome","volume":"71","author":"Coffee","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib146","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.pgen.1000017","article-title":"SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome","volume":"4","author":"Biacsi","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib147","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib148","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1093\/nar\/gkv993","article-title":"Nuclear domain \u201cknock-in\u201d screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing","volume":"43","author":"Pinder","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib149","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13073-015-0215-6","article-title":"Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing","volume":"7","author":"Robert","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib150","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.cell.2012.11.054","article-title":"An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression","volume":"151","author":"Srivastava","year":"2012","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib151","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1111\/febs.13416","article-title":"Inhibition of nonhomologous end joining to increase the specificity of CRISPR\/Cas9 genome editing","volume":"282","author":"Vartak","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib152","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.3198","article-title":"Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells","volume":"33","author":"Chu","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib153","doi-asserted-by":"crossref","first-page":"35861","DOI":"10.1038\/srep35861","article-title":"Fluorescent protein tagging of endogenous protein in brain neurons using CRISPR\/Cas9-mediated knock-in and in utero electroporation techniques","volume":"6","author":"Uemura","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib154","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib155","first-page":"1917","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awu352","article-title":"Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice","volume":"138","author":"Mendon\u00e7a","year":"2015","journal-title":"Brain"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib157","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib158","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib159","doi-asserted-by":"crossref","first-page":"13126","DOI":"10.1523\/JNEUROSCI.0647-09.2009","article-title":"Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model","volume":"29","author":"Chintawar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0963689718754560","article-title":"Combining Induced pluripotent stem cells and genome editing technologies for clinical applications","volume":"27","author":"Chang","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib161","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3389\/fnins.2019.01194","article-title":"Successes and hurdles in stem cells application and production for brain transplantation","volume":"13","author":"Henriques","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib162","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrm.2016.10","article-title":"Pluripotent stem cells progressing to the clinic","volume":"17","author":"Trounson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib164","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.scr.2015.12.048","article-title":"Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266","volume":"16","author":"Marthaler","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib165","doi-asserted-by":"crossref","first-page":"e0204735","DOI":"10.1371\/journal.pone.0204735","article-title":"Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells","volume":"13","author":"Morozova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib166","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-017-0475-z","article-title":"CRISPR\/Cas9-correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer\u2019s PSEN2 (N141I) neurons","volume":"5","author":"Ortiz-Virumbrales","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib167","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib168","first-page":"6","article-title":"Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR\/Cas9 system","author":"An","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib169","doi-asserted-by":"crossref","first-page":"101403","DOI":"10.1016\/j.scr.2019.101403","article-title":"Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene","volume":"35","author":"Frederiksen","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fgene.2019.00625","article-title":"Efficient and precise CRISPR\/Cas9-mediated MECP2 modifications in human-induced pluripotent stem cells","volume":"10","author":"Le","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib171","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-018-06676-2","article-title":"CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response","volume":"9","author":"Szlachta","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib172","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","article-title":"Induced pluripotent stem cells in Alzheimer\u2019s disease: applications for disease modeling and cell-replacement therapy","volume":"11","author":"Yang","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib173","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/febs.13750","article-title":"Using CRISPR\/Cas to study gene function and model disease in vivo","volume":"283","author":"Tschaharganeh","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib174","doi-asserted-by":"crossref","first-page":"20620","DOI":"10.1038\/srep20620","article-title":"One-step generation of triple gene-targeted pigs using CRISPR\/Cas9 system","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib175","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00018-014-1744-7","article-title":"Generation of CRISPR\/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer","volume":"72","author":"Zhou","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib176","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/cr.2017.95","article-title":"Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate","volume":"27","author":"Zhao","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib177","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1038\/s41598-018-30436-3","article-title":"CRISPR\/Cas9-mediated generation of Guangxi bama minipigs harboring three mutations in alpha-synuclein causing Parkinson\u2019s disease","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib178","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib179","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib180","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1038\/srep28420","article-title":"Precision modulation of neurodegenerative disease-related gene expression in human iPSC-derived neurons","volume":"6","author":"Heman-Ackah","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib181","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature12466","article-title":"Optical control of mammalian endogenous transcription and epigenetic states","volume":"500","author":"Konermann","year":"2013","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib182","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fnmol.2018.00282","article-title":"Targeted reactivation of FMR1 transcription in fragile X syndrome embryonic stem cells","volume":"11","author":"Haenfler","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib183","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-319-53889-1_21","article-title":"Epigenome editing in the brain","author":"Bashtrykov","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib184","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.6254144","article-title":"DNA methylation and gene function","volume":"210","author":"Razin","year":"1980","journal-title":"Science"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib185","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib186","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","article-title":"Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD","volume":"26","author":"Kantor","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib187","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.2174\/138161211798072472","article-title":"Gene therapy for Parkinson\u2019s and Alzheimer\u2019s diseases: from the bench to clinical trials","volume":"17","author":"Nobre","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"Pt 4","key":"10.1016\/B978-0-12-818084-6.00011-8_bib188","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/0022-1317-73-4-961","article-title":"Detection of adeno-associated virus type 2 in human peripheral blood cells","volume":"73","author":"Grossman","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib189","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","article-title":"Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector","volume":"713","author":"McCown","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib190","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/gt.2008.68","article-title":"Clinical gene therapy using recombinant adeno-associated virus vectors","volume":"15","author":"Mueller","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib191","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib192","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.ymgme.2018.12.301","article-title":"Intranasal delivery of the CRISPR-Cas9 system for gene editing in MPS II mice","volume":"126","author":"Pimentel","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib193","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib194","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","article-title":"Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours","volume":"2","author":"Lee","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair","volume":"1","author":"Lee","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib196","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib197","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","article-title":"Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population","volume":"10","author":"Simhadri","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib198","doi-asserted-by":"crossref","unstructured":"C.T. Charlesworth, P.S. Deshpande, D.P. Dever, B. Dejene, N. Gomez-Ospina, S. Mantri, et al., Identification of Pre-Existing Adaptive Immunity to Cas9 Proteins in Humans, bioRxiv, 2018.","DOI":"10.1101\/243345"},{"key":"10.1016\/B978-0-12-818084-6.00011-8_bib199","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"}],"container-title":["Handbook of Innovations in Central Nervous System Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128180846000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128180846000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T13:34:46Z","timestamp":1757684086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128180846000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128180846"],"references-count":199,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-818084-6.00011-8","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}